Product Description

CANDI-3 Softgel Capsules contain Clindamycin 100 mg, Clotrimazole 100 mg and Tinidazole 100 mg in a vaginal softgel capsule formulation.

The combination provides antibacterial, antifungal and antiprotozoal activity and is intended for the management of clinically diagnosed vaginal infections involving susceptible organisms, as determined by a healthcare professional.

CANDI-3 is supplied as 10 × 1 × 7 vaginal softgel capsules, providing a total of 70 capsules per pack.

Therapeutic Uses

CANDI-3 may be prescribed for clinically diagnosed vaginal infections involving susceptible bacterial, fungal or protozoal organisms, depending on the patient’s diagnosis.

It may be relevant to mixed vaginal infections where treatment against more than one type of organism is clinically indicated.

NOTE : The specific diagnosis and appropriate treatment should be determined by a qualified healthcare professional.